Categories: News

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) — Life Sciences Investor Forum today announced that the presentations from the March 25th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.

REGISTER OR LOGIN AT:  https://bit.ly/3tThRej

March 25th Presenting Companies:

Presenting Company Ticker(s)
MagicMed Industries Inc. Ticker Pending
Sernova Corp. OTCQB: SEOVF | TSX-V: SVA
VolitionRx Limited NYSE AMERICAN: VNRX
Skylight Health Group Inc. OTCQX: SHGFF | TSX-V:SHG
Else Nutrition Holdings Inc. OTCQX: BABYF | TSX-V: BABY
Cardiol Therapeutics Inc. OTCQX: CRTPF | TSX: CRDL
EarthRenew Inc. OTCQB: VVIVF | CSE: ERTH
Avicanna Inc. OTCQX: AVCNF | TSX: AVCN
Orexo AB OTCQX: ORXOY | STO: ORX
CloudMD Software & Services Inc. Pink: DOCRF | TSX-V: DOC

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACT: CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

14 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

14 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago